Immediate Impact
58 standout
Citing Papers
Advances in targeting histone deacetylase for treatment of solid tumors
2024 Standout
Tumor biomarkers for diagnosis, prognosis and targeted therapy
2024 Standout
Works of Yuichiro Tada being referenced
Phase II Trial of Trastuzumab and Docetaxel in Patients With Human Epidermal Growth Factor Receptor 2–Positive Salivary Duct Carcinoma
2018
A prospective phase II study of combined androgen blockade in patients with androgen receptor-positive metastatic or locally advanced unresectable salivary gland carcinoma
2017
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Yuichiro Tada | 843 | 750 | 230 | 256 | 86 | 1.2k | |
| Stephan Ihrler | 1143 | 782 | 209 | 270 | 86 | 1.7k | |
| Albina Altemani | 765 | 610 | 266 | 166 | 112 | 1.3k | |
| Fabrício Passador‐Santos | 950 | 878 | 77 | 310 | 61 | 1.4k | |
| Robert P. Zitsch | 737 | 668 | 517 | 104 | 74 | 1.3k | |
| Juan C. Hernandez‐Prera | 549 | 415 | 233 | 140 | 66 | 1.2k | |
| Tsu‐Hui Low | 817 | 477 | 679 | 101 | 127 | 1.6k | |
| Andrés Coca‐Pelaz | 723 | 631 | 336 | 87 | 79 | 1.3k | |
| Gwi Eon Kim | 530 | 800 | 322 | 454 | 63 | 1.7k | |
| Kwang Hyun Kim | 825 | 325 | 390 | 124 | 74 | 1.4k | |
| K. Thomas Robbins | 551 | 414 | 447 | 166 | 48 | 1.2k |
All Works
Login with ORCID to disown or claim papers
Loading papers...